Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

Angela Merkel: Glyphosate Use Will Eventually End

Popular
Germany's Chancellor Angela Merkel speaks to the press as she arrives for an European Council Summit at The Europa Building in Brussels, on June 20. ARIS OIKONOMOU / AFP / Getty Images

German Chancellor Angela Merkel told her country's lower house of government that use of the controversial herbicide glyphosate will eventually die out, according to Reuters.


Her new comments update steps she and her coalition government made to limit glyphosate use as a way to phase out its use and to put in new conditions and restrictions for new pesticides and herbicides entering the marketplace.

"Things are developing, and we will eventually come to a point where glyphosate isn't deployed any more," she told lawmakers, as Reuters reported. She added that a gradual end of glyphosate, or RoundUp, should not overburden farmers.

Bayer AG, the company that owns the herbicide after it acquired seed maker Monsanto, faces lawsuits by more than 13,400 plaintiffs in the U.S. who claim the herbicide caused cancer. A jury award of over $2 billion caused the company's stock to plummet to a seven-year low last month.

Yet, Bayer sees a bright future for glyphosate, despite Merkel's comments and the wave of litigation. Merkel's comments did little to deter investors. In fact, the same day that Merkel said she saw an end to glyphosate in Germany, Bayer shares jumped when the company shared plans to resolving the multibillion-dollar lawsuits it faces, as Reuters reported.

Bayer maintains that glyphosate is safe to use and does not cause cancer. So, it appointed a trial lawyer known for no-holds barred tenacity to its advisory board, according to Bloomberg.

Last week, it asked a California judge to reverse the $2 billion jury-award, claiming that it was based on "inflammatory, fabricated and irrelevant evidence" from the couples' lawyers, as Reuters reported.


"The resulting trial focused not on ascertaining the truth regarding the state of the science, causation, and compliance with legal duties, but instead on vilifying Monsanto in the abstract," Bayer said in motions filed with the court, according to Reuters.

Bayer's next glyphosate trial will start this summer in St. Louis, the former headquarters of Monsanto. The company will likely be embroiled in lengthy-litigation for years to come. Major shareholders criticized Bayer's position. They accused Bayer of mismanaging the glyphosate issue and disapproved of management, according to Reuters.

Even though Bayer maintains that scientific-evidence proves glyphosate's safety and efficacy, governments around the world have started to ban its use. Therefore, Bayer has responded to the demands of the market and said it would invest more than $5.5 billion in researching alternative herbicides.

"While glyphosate will continue to play an important role in agriculture and in Bayer's portfolio, the company is committed to offering more choices for growers," Bayer said, as Reuters reported.

EcoWatch Daily Newsletter

A scenic view of West Papua. Reza Fakhrudin / Pexels

By Arkilaus Kladit

My name is Arkilaus Kladit. I'm from the Knasaimos-Tehit tribe in South Sorong Regency, West Papua Province, Indonesia. For decades my tribe has been fighting to protect our forests from outsiders who want to log it or clear it for palm oil. For my people, the forest is our mother and our best friend. Everything we need to survive comes from the forest: food, medicines, building materials, and there are many sacred sites in the forest.

Read More Show Less
Everyone overthinks their lives or options every once in a while. Some people, however, can't stop the wheels and halt their train of thoughts. Peter Griffith / Getty Images

By Farah Aqel

Overthinkers are people who are buried in their own obsessive thoughts. Imagine being in a large maze where each turn leads into an even deeper and knottier tangle of catastrophic, distressing events — that is what it feels like to them when they think about the issues that confront them.

Read More Show Less
A newly developed catalyst would transform carbon dioxide from power plants and other sources into ethanol. DWalker44 / E+ / Getty Images

Researchers at the Department of Energy's Argonne National Laboratory have discovered a cheap, efficient way to convert carbon dioxide into liquid fuel, potentially reducing the amount of new carbon dioxide pumped into the atmosphere.

Read More Show Less
Eureka Sound on Ellesmere Island in the Canadian Arctic taken by NASA's Operation IceBridge in 2014. NASA / Michael Studinger / Flickr / CC by 2.0

A 4,000-year-old ice shelf in the Canadian Arctic has collapsed into the sea, leaving Canada without any fully intact ice shelves, Reuters reported. The Milne Ice Shelf lost more than 40 percent of its area in just two days at the end of July, said researchers who monitored its collapse.

Read More Show Less
Teachers and activists attend a protest hosted by Chicago Teachers Union in Chicago, Illinois on Aug. 3, 2020 to demand classroom safety measures as schools debate reopening. KAMIL KRZACZYNSKI / AFP via Getty Images

The coronavirus cases surging around the U.S. are often carried by kids, raising fears that the reopening of schools will be delayed and calling into question the wisdom of school districts that have reopened already.

Read More Show Less
Prime Minister Jacinda Ardern holds up COVID-19 alert levels during a press conference at Parliament on March 21, 2020 in Wellington, New Zealand. Hagen Hopkins / Getty Images

By Michael Baker, Amanda Kvalsvig and Nick Wilson

On Sunday, New Zealand marked 100 days without community transmission of COVID-19.

Read More Show Less

Trending

Medics with Austin-Travis County EMS transport a nursing home resident with coronavirus symptoms on Aug. 3, 2020 in Austin, Texas. John Moore / Getty Images

The U.S. passed five million coronavirus cases on Sunday, according to data from Johns Hopkins University, just 17 days after it hit the four-million case mark.

Read More Show Less